Codagenix
A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York.
5
Funding Rounds
$26.8m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch***** Pe*** | - | - | - |
| Gl*** Ro***** | - | - | - |
| St***** Mu***** | - | - | - |
| Ec**** Wi**** | - | - | - |
| J. Ro**** Co***** | - | - |
Funding
Funding series
Funding Series Analysis
The company Codagenix has raised a total of $26.8m in funding over 5 rounds.
Key Insights:
- Codagenix Series B round, January 2020: $20m
- Codagenix Venture round, October 2017: $3m
- Codagenix Series A round, June 2015: $2m
- Codagenix Grant (money), June 2014: $1.2m
- Codagenix Grant (money), July 2012: $600k
Codagenix Series B round, January 2020
$20m
Codagenix Venture round, October 2017
$3m
Codagenix Series A round, June 2015
$2m
Codagenix Grant (money), June 2014
$1.2m
Codagenix Grant (money), July 2012
$600k
Industries
Codagenix is active in the following industries: